Software-driven risk
For software, SaMD and AI/ML-enabled medical devices, with public FDA records supporting the review of existing FMEA and hazard-analysis files.
FMEAi / PRODUCT CASE STUDY
FMEAi is an AI risk intelligence product built by HighCloud for medical-device and energy risk workflows. It shows how source-linked evidence, AI-assisted analysis and human review can work together in a practical product.
FMEAi is owned by HighCloud.
A practical AI product case study.
Medical-device teams need to assess evolving failure modes against a growing public evidence base. Manual reviews can make it difficult to identify relevant signals and keep findings traceable.
FMEAi compares existing FMEA and hazard analysis files with AI-derived failure modes and public FDA records, then presents evidence-linked findings for a team to review.
PURPOSE IN PRACTICE
FMEAi’s mission is to advance patient safety by preventing harm before products reach patients. Its medical-device profile focuses on software, Software as a Medical Device (SaMD), and AI/ML-enabled devices.
Built for these software-driven devices, FMEAi works alongside existing risk tools rather than requiring a QMS migration.
The medical-device profile uses FDA MAUDE, recalls, enforcement actions and 510(k) records. The energy profile uses PHMSA incident data, NTSB reports and state commission records.
Read the product detailsThe mission behind FMEAiEvery finding links to its source.
Illustrative medical-device workflow · not a product screenshot
ONE ENGINE. INDUSTRY-SPECIFIC CONTEXT.
The current public FMEAi site describes two industry profiles sharing import, gap scans, citations and governed review. These are product capabilities; not customer ROI figures.
For software, SaMD and AI/ML-enabled medical devices, with public FDA records supporting the review of existing FMEA and hazard-analysis files.
For electric and gas utilities, with asset FMEA gap scans referencing PHMSA, NTSB and state commission evidence.
WHAT HIGHCLOUD BUILT
The useful part isn’t just generating an answer. It’s how evidence, roles and decisions connect around it.
AI-generated observations link back to public records so reviewers can examine the basis for a finding.
Engineer review and a separate risk approver govern official record changes. An AI draft is not the authoritative record.
Software, firmware and AI/ML failure modes are considered alongside risk signals, versioned drafts and project-scoped roles. FMEAi works with existing risk tools rather than requiring a rip-and-replace migration.
THE PRODUCT WORKFLOW
Capabilities described here reflect the public FMEAi product site. Automated monitoring is on its roadmap and is not presented as a current capability.
Start with the FMEA or hazard analysis your team already uses.
Compare the file against AI-derived failure modes and public FDA evidence.
Your qualified team examines the evidence and controls the disposition of findings.
Product capabilities and design approach; not quantified customer outcomes, independent validation, FDA approval or a guarantee of regulatory compliance. FMEAi supports qualified professionals; it does not replace them. Product and mission sources: fmeai.ai and FMEAi About.
YOUR NEXT PROJECT
Tell us what is blocking progress.
Let's find a practical engineering next step.